Multi-spectral Pattern of Clinical Presentation and the Resultant Outcome in Central Nervous System Tuberculosis: A Single Center Study on the Ubiquitous Pathogen
- 20 Downloads
Central nervous system (CNS) tuberculosis (TB) is a great medical masquerader having a multi-spectral pattern of clinical presentation, thereby complicating early diagnosis and appropriate management. This review article describes clinical presentation of CNS TB in a group of 47 patients, who were managed in the Nobel Medical College and Teaching Hospital in Biratnagar, Nepal during the last 2 years. We evaluated demographic profile, mode of management, and clinical outcome in these patients. The findings were that intracranial TB was present in 27 (57.5%) patients and the spinal involvement was in 20 (42.5%) patients. The most frequent presentation of the former was TB meningitis with hydrocephalus (55.5%) and that of the latter was Pott’s spine with abscess in 50% of cases. TB meningitis with hydrocephalus was the commonest cause of mortality (83.3%) among the patients. CNS TB should be considered in the differential diagnosis in patients presenting with equivocal neurological signs and symptoms, especially in TB endemic regions. It seems prudent to commence early antitubercular therapy for safeguarding such patients from poor neurological outcome as well as mortality it harbingers.
KeywordsCentral nervous system Clinical outcome Differential diagnosis Meningitis Pott’s spine Tuberculosis
Conflicts of Interest
The authors declare no conflicts of interest in relation to this article.
All procedures and studies described in this review were conducted in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The article gained approval from the Institutional Review Committee of the Nobel Medical College and Teaching Hospital (IRC-279/2019).
As there was no current involvement of any human studies in this review article, consent from individual participants was not required.
- Bloom BR, Atun R, Cohen T, Dye C, Fraser H, Gomez GB, Knight G, Murray M, Nardell E, Rubin E, Salomon J, Vassall A, Volchenkov G, White R, Wilson D, Yadav P (2017) Chapter 11: Tuberculosis. In: Holmes KK, Bertozzi S, Bloom BR, Prabhat J (eds) Major infectious diseases, 3rd edn. The International Bank for Reconstruction and Development/The World Bank, Washington, DC. Available from: https://www.ncbi.nlm.nih.gov/books/NBK525174/. Accessed on 26 Nov 2019. https://doi.org/10.1596/978-1-4648-0524-0/ch11
- National Tuberculosis Center (2019) Government of Nepal, Ministry of Health & Population, Department of health services. https://nepalntp.gov.np/. Accessed on 25 Oct 2019
- National Tuberculosis Program (2017) Nepal Annual Report 2073/2074. Goverment of Nepal Ministry of Health Department of Health Services National Tuberculosis Center. https://nepalntp.gov.np/wp-content/uploads/2018/03/Final-Annual-Report-NTPN-2018.pdf. Accessed on 27 Nov 2019
- Robertson FC, Lepard JR, Mekary RA, Davis MC, Yunusa I, Gormley WB, Baticulon RE, Mahmud MR, Misra BK, Rattani A, Dewan MC, Park KB (2018) Epidemiology of central nervous system infectious diseases: a meta-analysis and systematic review with implications for neurosurgeons worldwide. J Neurosurg 1:1–20. https://doi.org/10.3171/2017.10.JNS17359. (Epub ahead of print)CrossRefGoogle Scholar
- Sinha K, Marak IT, Singh W (2013) Adverse drug reactions in tuberculosis patients due to directly observed treatment strategy therapy: experience at an outpatient clinic of a teaching hospital in the city of Imphal, Manipur, India. J Assoc Chest Phys 1(2):50. https://doi.org/10.4103/2320-8775.123213CrossRefGoogle Scholar
- Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, Nguyen TC, Nguyen QH, Nguyen TT, Nguyen NH, Nguyen TN, Nguyen NL, Nguyen HD, Vu NT, Cao HH, Tran TH, Pham PM, Nguyen TD, Stepniewska K, White NJ, Tran TH, Farrar JJ (2004) Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. New Engl J Med 351(17):1741–1751CrossRefGoogle Scholar
- WHO (1997) World Health Organization. Guidelines on the management of drug-resistant tuberculosis. WHO/TB/96.210; Geneva WHO; https://apps.who.int/iris/bitstream/handle/10665/63465/WHO_TB_96.210_(Rev.1).pdf;jsessionid=D5AC6877CD226400C1DAA4A1FF6694FC?sequence=1. Accessed on 26 Nov 2019